Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes

Jennifer L. Illuzzi, Daniel R. McNeill, Paul Bastian, Boris Brenerman, Robert Wersto, Helen R. Russell, Fred Bunz, Peter J. McKinnon, Kevin G. Becker, David M. Wilson

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds